Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105.

Kumagai Y, Sobajima J, Higashi M, Ishiguro T, Fukuchi M, Ishibashi K, Baba H, Mochiki E, Yakabi K, Kawano T, Tamaru J, Ishida H.

Jpn J Clin Oncol. 2014 Jun;44(6):526-33. doi: 10.1093/jjco/hyu039. Epub 2014 Apr 19.

2.

Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.

Sakurai T, Okumura H, Matsumoto M, Uchikado Y, Owaki T, Kita Y, Setoyama T, Omoto I, Kijima Y, Ishigami S, Natsugoe S.

Anticancer Res. 2014 Jul;34(7):3431-8.

PMID:
24982351
3.

Microvessel density assessment in benign and malignant endometrial changes.

Czekierdowski A, Czekierdowska S, Czuba B, Cnota W, Sodowski K, Kotarski J, Zwirska-Korczala K.

J Physiol Pharmacol. 2008 Sep;59 Suppl 4:45-51.

4.

Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue.

Eshghyar N, Mohammadi N, Rahrotaban S, Motahhary P, Vahedi Vaez SM.

Arch Iran Med. 2011 Jul;14(4):276-80. doi: 0011144/AIM.0010.

5.

RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.

Zhao ZH, Tian Y, Yang JP, Zhou J, Chen KS.

World J Gastroenterol. 2015 Jan 21;21(3):905-12. doi: 10.3748/wjg.v21.i3.905.

6.

[Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma].

Bodnar M, Szylberg Ł, Kaźmierczak W, Marszałek A.

Przegl Lek. 2012;69(10):726-30. Polish.

PMID:
23421020
7.

Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.

Zvrko E, Mikic A, Vuckovic L, Djukic V, Knezevic M.

Otolaryngol Head Neck Surg. 2009 Oct;141(4):478-83. doi: 10.1016/j.otohns.2009.07.001.

PMID:
19786216
8.

Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma.

Li SL, Gao DL, Zhao ZH, Liu ZW, Zhao QM, Yu JX, Chen KS, Zhang YH.

World J Gastroenterol. 2007 Dec 7;13(45):6076-81.

9.

[Relationship between CD105 and angiogenesis and biological behaviors in squamous carcinoma of larynx].

Gu X, Xu Y, Wu H, Xu X.

Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006 Feb;20(3):125-8. Chinese.

PMID:
16646406
10.

Immunohistochemical evaluation of angiogenesis and tryptase-positive mast cell infiltration in periapical lesions.

Lima SC, Rizo VH, Silva-Sousa YT, Almeida LY, Almeida OP, León JE.

J Endod. 2011 Dec;37(12):1642-6. doi: 10.1016/j.joen.2011.08.024. Epub 2011 Sep 29.

PMID:
22099897
11.

Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.

Paschoal JP, Bernardo V, Canedo NH, Ribeiro OD, Caroli-Bottino A, Pannain VL.

BMC Cancer. 2014 Feb 7;14:72. doi: 10.1186/1471-2407-14-72.

12.

Expression of non-mast cell histidine decarboxylase in tumor-associated microvessels in human esophageal squamous cell carcinomas.

Li Z, Liu J, Tang F, Liu Y, Waldum HL, Cui G.

APMIS. 2008 Dec;116(12):1034-42. doi: 10.1111/j.1600-0463.2008.01048.x.

PMID:
19133005
13.

Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.

Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S.

Hum Pathol. 2006 Jul;37(7):861-6. Epub 2006 May 19.

PMID:
16784986
14.

A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma.

Marioni G, Staffieri A, Manzato E, Ralli G, Lionello M, Giacomelli L, Prosenikliev V, Marchese-Ragona R, Busnardo A, Bolzetta F, Blandamura S.

Arch Otolaryngol Head Neck Surg. 2011 Feb;137(2):175-80. doi: 10.1001/archoto.2010.244.

PMID:
21339405
15.
16.

Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.

Miyata Y, Mitsunari K, Asai A, Takehara K, Mochizuki Y, Sakai H.

Prostate. 2015 Jan;75(1):84-91. doi: 10.1002/pros.22894. Epub 2014 Oct 13.

17.

BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.

Ratajczak P, Leboeuf C, Wang L, Brière J, Loisel-Ferreira I, Thiéblemont C, Zhao WL, Janin A.

Mod Pathol. 2012 Jun;25(6):805-14. doi: 10.1038/modpathol.2012.1. Epub 2012 Feb 10.

18.

The onset of angiogenesis in a multistep process of esophageal squamous cell carcinoma.

Kubota Y, Kaneko K, Konishi K, Ito H, Yamamoto T, Katagiri A, Muramoto T, Yano Y, Kobayashi Y, Oyama T, Kushima M, Imawari M.

Front Biosci (Landmark Ed). 2009 Jan 1;14:3872-8.

PMID:
19273317
19.

Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.

Medetoglu B, Gunluoglu MZ, Demir A, Melek H, Buyukpinarbasili N, Fener N, Dincer SI.

J Thorac Cardiovasc Surg. 2010 Nov;140(5):996-1000. doi: 10.1016/j.jtcvs.2010.07.002. Epub 2010 Aug 13.

PMID:
20708755
20.

Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors.

Adam M, Schmidt D, Wardelmann E, Wernert N, Albers P.

Eur Urol. 2003 Sep;44(3):329-36.

PMID:
12932931
Items per page

Supplemental Content

Write to the Help Desk